Renal Artery Denervation for Treating Resistant Hypertension

[1]  H. Krum,et al.  Renal denervation in moderate to severe CKD. , 2012, Journal of the American Society of Nephrology : JASN.

[2]  E. Guallar,et al.  Survey of physicians’ practices in the control of cardiovascular risk factors: the EURIKA study , 2012, European journal of preventive cardiology.

[3]  G. Mancia,et al.  Blood pressure control in Italy: analysis of clinical data from 2005–2011 surveys on hypertension , 2012, Journal of hypertension.

[4]  G. Parati,et al.  ESH position paper: renal denervation - an interventional therapy of resistant hypertension. , 2012, Journal of hypertension.

[5]  J. Wellmann,et al.  Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey , 2011, Journal of hypertension.

[6]  H. Krum,et al.  Renal denervation and hypertension. , 2011, American journal of hypertension.

[7]  Symplicity Htn Investigators,et al.  Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: Durability of Blood Pressure Reduction Out to 24 Months , 2011, Hypertension.

[8]  H. Krum,et al.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial , 2010, The Lancet.

[9]  M. Böhm,et al.  A Global Perspective on Blood Pressure Treatment and Control in a Referred Cohort of Hypertensive Patients , 2010, Journal of clinical hypertension.

[10]  M. Volpe,et al.  Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice , 2010, Expert review of cardiovascular therapy.

[11]  W. J. Elliott,et al.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study , 2010 .

[12]  A. Chobanian Shattuck Lecture. The hypertension paradox--more uncontrolled disease despite improved therapy. , 2009, The New England journal of medicine.

[13]  Henry Krum,et al.  Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. , 2009, Hypertension.

[14]  S. Oparil,et al.  Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension , 2009, Journal of hypertension.

[15]  G. Bakris,et al.  Resistant hypertension: an overview of evaluation and treatment. , 2008, Journal of the American College of Cardiology.

[16]  B Neal,et al.  Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials , 2008, BMJ : British Medical Journal.

[17]  R. Collins,et al.  Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.

[18]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[19]  G. Mancia,et al.  Blood pressure control in Italy: results of recent surveys on hypertension , 2007, Journal of hypertension.

[20]  N. Chapman,et al.  Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension , 2007, Hypertension.

[21]  Neil Chapman,et al.  Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. , 2005, Archives of internal medicine.

[22]  F. Turnbull Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.

[23]  J. Staessen,et al.  Essential hypertension , 2003, The Lancet.

[24]  Yutaka Imai,et al.  European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement , 2003, Journal of hypertension.

[25]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[26]  Sc Prospective,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002 .